Recombinant Human Erythropoietin β (CHO Cell)(Shanghai Roche)
重组人促红素-β(CHO细胞)(上海罗氏)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant Human Erythropoietin β (CHO Cell)(Shanghai Roche)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShanghai Roche Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A